Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 27, 2020, George Abercrombie informed Brickell Biotech, Inc. (the
"Company") of his resignation from the Company's Board of Directors, effective
immediately. In submitting his resignation, Mr. Abercrombie did not express any
disagreement on any matter relating to the operations, policies or practices of
the Company.
In connection with Mr. Abercrombie's resignation, and in accordance with the
Company's By-Laws, the Board of Directors of the Company reduced the size of the
Board from six members to five members.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses